- Home
- PCRX vs JKS Comparison
PCRX vs JKS Comparison
Compare PCRX & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- JKS
- Stock Information
- Founded
- PCRX 2006
- JKS 2006
- Country
- PCRX United States
- JKS China
- Employees
- PCRX N/A
- JKS N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- JKS Semiconductors
- Sector
- PCRX Health Care
- JKS Technology
- Exchange
- PCRX Nasdaq
- JKS Nasdaq
- Market Cap
- PCRX 1.2B
- JKS 1.3B
- IPO Year
- PCRX 2011
- JKS 2010
- Fundamental
- Price
- PCRX $22.07
- JKS $21.52
- Analyst Decision
- PCRX Buy
- JKS Hold
- Analyst Count
- PCRX 8
- JKS 5
- Target Price
- PCRX $28.38
- JKS $27.19
- AVG Volume (30 Days)
- PCRX 590.9K
- JKS 660.9K
- Earning Date
- PCRX 08-05-2025
- JKS 08-29-2025
- Dividend Yield
- PCRX N/A
- JKS 6.97%
- EPS Growth
- PCRX N/A
- JKS N/A
- EPS
- PCRX N/A
- JKS N/A
- Revenue
- PCRX $702,772,000.00
- JKS $11,445,691,729.00
- Revenue This Year
- PCRX $7.90
- JKS N/A
- Revenue Next Year
- PCRX $11.02
- JKS $31.21
- P/E Ratio
- PCRX N/A
- JKS N/A
- Revenue Growth
- PCRX 3.08
- JKS N/A
- 52 Week Low
- PCRX $11.16
- JKS $13.42
- 52 Week High
- PCRX $27.64
- JKS $37.36
- Technical
- Relative Strength Index (RSI)
- PCRX 44.39
- JKS 40.52
- Support Level
- PCRX $20.85
- JKS $22.81
- Resistance Level
- PCRX $22.32
- JKS $23.48
- Average True Range (ATR)
- PCRX 0.84
- JKS 0.94
- MACD
- PCRX 0.01
- JKS -0.43
- Stochastic Oscillator
- PCRX 44.69
- JKS 10.07
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.